1. Home
  2. ABP vs MTEX Comparison

ABP vs MTEX Comparison

Compare ABP & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • MTEX
  • Stock Information
  • Founded
  • ABP 2004
  • MTEX 1993
  • Country
  • ABP United States
  • MTEX United States
  • Employees
  • ABP N/A
  • MTEX N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • ABP Health Care
  • MTEX Health Care
  • Exchange
  • ABP Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • ABP 17.2M
  • MTEX 15.8M
  • IPO Year
  • ABP N/A
  • MTEX 1999
  • Fundamental
  • Price
  • ABP $0.18
  • MTEX $7.80
  • Analyst Decision
  • ABP Strong Buy
  • MTEX
  • Analyst Count
  • ABP 1
  • MTEX 0
  • Target Price
  • ABP $4.00
  • MTEX N/A
  • AVG Volume (30 Days)
  • ABP 3.2M
  • MTEX 10.4K
  • Earning Date
  • ABP 08-13-2025
  • MTEX 11-11-2025
  • Dividend Yield
  • ABP N/A
  • MTEX N/A
  • EPS Growth
  • ABP N/A
  • MTEX N/A
  • EPS
  • ABP N/A
  • MTEX N/A
  • Revenue
  • ABP $183,000.00
  • MTEX $112,975,000.00
  • Revenue This Year
  • ABP N/A
  • MTEX N/A
  • Revenue Next Year
  • ABP N/A
  • MTEX N/A
  • P/E Ratio
  • ABP N/A
  • MTEX N/A
  • Revenue Growth
  • ABP 154.17
  • MTEX N/A
  • 52 Week Low
  • ABP $0.15
  • MTEX $7.05
  • 52 Week High
  • ABP $11.19
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • ABP 35.07
  • MTEX 41.05
  • Support Level
  • ABP $0.16
  • MTEX $8.21
  • Resistance Level
  • ABP $0.26
  • MTEX $9.80
  • Average True Range (ATR)
  • ABP 0.02
  • MTEX 0.74
  • MACD
  • ABP -0.01
  • MTEX -0.14
  • Stochastic Oscillator
  • ABP 19.90
  • MTEX 0.00

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: